Kementec Solutions A/S: Financial statements 2016
CVR: 25806735
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 13,355,814 and a net result of DKK 3,646,072 compared with DKK 3,694,124 the year before. That is a decrease of 4.5% compared with the year before. Equity in the 2016 report amounted to DKK 7,386,439. The solvency ratio was 54.4%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 13,355,814
- Profit/Loss
- DKK 3,646,072
- Equity
- DKK 7,386,439
- Total Assets
- DKK 13,585,947
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 13.4 mio. | 3.6 mio. | 7.4 mio. | 16 |
| 2015 | - | 14 mio. | 3.7 mio. | 6.3 mio. | - |
| 2014 | - | 10.5 mio. | 1.7 mio. | 5.1 mio. | - |
| 2013 | - | 11.5 mio. | 2.4 mio. | 4.9 mio. | - |
| 2012 | - | 10.4 mio. | 1.1 mio. | 3.6 mio. | - |
Official annual report
Find more companies like Kementec Solutions A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
Kementec Solutions A/S has published its annual report for 2015. Gross profit came to DKK 13,986,577, and the net result was DKK 3,694,124.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.